ICU
Price
$0.60
Change
-$0.01 (-1.64%)
Updated
Sep 26 closing price
Capitalization
16.81M
KNTPF
Price
$0.26
Change
-$0.02 (-7.14%)
Updated
Sep 3 closing price
Capitalization
134.14M
Interact to see
Advertisement

ICU vs KNTPF

Header iconICU vs KNTPF Comparison
Open Charts ICU vs KNTPFBanner chart's image
SeaStar Medical Holding
Price$0.60
Change-$0.01 (-1.64%)
Volume$3.74M
Capitalization16.81M
KINTOR PHARMACEUTICAL
Price$0.26
Change-$0.02 (-7.14%)
Volume$460
Capitalization134.14M
ICU vs KNTPF Comparison Chart in %
Loading...
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICU vs. KNTPF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICU is a Hold and KNTPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (ICU: $0.60 vs. KNTPF: $0.26)
Brand notoriety: ICU and KNTPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICU: 157% vs. KNTPF: 93%
Market capitalization -- ICU: $16.81M vs. KNTPF: $134.14M
ICU [@Biotechnology] is valued at $16.81M. KNTPF’s [@Biotechnology] market capitalization is $134.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICU’s FA Score shows that 0 FA rating(s) are green whileKNTPF’s FA Score has 0 green FA rating(s).

  • ICU’s FA Score: 0 green, 5 red.
  • KNTPF’s FA Score: 0 green, 5 red.
According to our system of comparison, KNTPF is a better buy in the long-term than ICU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICU’s TA Score shows that 3 TA indicator(s) are bullish while KNTPF’s TA Score has 2 bullish TA indicator(s).

  • ICU’s TA Score: 3 bullish, 6 bearish.
  • KNTPF’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, KNTPF is a better buy in the short-term than ICU.

Price Growth

ICU (@Biotechnology) experienced а -33.22% price change this week, while KNTPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNTPF($134M) has a higher market cap than ICU($16.8M). KNTPF YTD gains are higher at: 61.750 vs. ICU (-68.959).
ICUKNTPFICU / KNTPF
Capitalization16.8M134M13%
EBITDA-14.63MN/A-
Gain YTD-68.95961.750-112%
P/E RatioN/AN/A-
Revenue766KN/A-
Total Cash6.3MN/A-
Total Debt363KN/A-
TECHNICAL ANALYSIS
Technical Analysis
ICUKNTPF
RSI
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
38%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
33%
MACD
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
34%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 5 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
33%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNTPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGC24.110.47
+1.99%
Kinross Gold Corp
ENTA7.900.15
+1.94%
Enanta Pharmaceuticals
VTEX4.32N/A
N/A
VTEX
VAL50.40-0.05
-0.10%
Valaris Limited
ELSE4.73-0.15
-3.16%
Electro-Sensors

ICU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICU has been closely correlated with NCNA. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICU jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICU
1D Price
Change %
ICU100%
-1.00%
NCNA - ICU
83%
Closely correlated
+0.75%
CDTX - ICU
83%
Closely correlated
+6.77%
TAOX - ICU
83%
Closely correlated
+6.95%
NBY - ICU
83%
Closely correlated
+2.34%
TNXP - ICU
82%
Closely correlated
+0.87%
More

KNTPF and

Correlation & Price change

A.I.dvisor tells us that KNTPF and ICU have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNTPF and ICU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTPF
1D Price
Change %
KNTPF100%
N/A
ICU - KNTPF
22%
Poorly correlated
-1.00%
ATON - KNTPF
8%
Poorly correlated
-7.68%
CNTB - KNTPF
3%
Poorly correlated
-6.51%
BCTX - KNTPF
2%
Poorly correlated
+3.08%
LVTX - KNTPF
2%
Poorly correlated
+0.12%
More